Oliver Loxley
Partner

Outline
Oliver's practice is focused on corporate finance, including debt and equity capital markets, institutional lending and other capital raising activities. He represents issuers, underwriters, financial sponsors and other investors in domestic and international transactions.
Overview
Client Work
The Initial Consenting Senior Secured Noteholders of Sherritt International Corporation, a nickel and cobalt producer and refiner, in connection with a note exchange and recapitalization by way of Court-approved plan of arrangement
Waste Connections in its C$500-million inaugural offering of senior notes
Medicus Pharma Ltd., in its acquisition of Antev Limited, a clinical stage biotech company, developing Teverelix, a next generation GnRH antagonist, as first in market product for cardiovascular high-risk prostate cancer patients and patients with first acute urinary retention episodes due to enlarged prostate, for consideration of up to approximately US$75 million.
Related Services
Education & Bar Admissions
Education
- University of British Columbia, BSc (Hons)
- University of British Columbia, JD
Bar Admissions
- New York
- Ontario
- British Columbia